The National Institutes of Health (NIH) plans to publish a funding opportunity announcement for the Type 1 Diabetes TrialNet Clinical Network Hub (U01 Clinical Trial Not Allowed). This initiative aims to support the TrialNet Clinical Network Hub (HUB), which serves as a coordination unit for clinical trials focused on preventing and intervening early in type 1 diabetes (T1D). The HUB's main objective is to enhance the efficiency and productivity of the TrialNet network by coordinating communications and outreach, developing new tools and approaches for screening, recruitment, and retention. The funding opportunity will require applicants to include a Plan for Enhancing Diverse Perspectives (PEDP) as part of the scientific and technical peer review evaluation. Failure to include a PEDP will result in the application being considered incomplete and withdrawn. The funding opportunity is expected to be published in Spring 2024, with an application due date in Summer 2024. The funding instrument type for this opportunity is a Cooperative Agreement, and the estimated total program funding is $1,000,000.